ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
ABPRO HLDGS INC
0.5220
0.0000
成交量:
- -
成交额:
- -
市值:
141.79万
市盈率:
-0.04
高:
0.5220
开:
0.5220
低:
0.5220
收:
0.5220
52周最高:
29.97
52周最低:
0.5171
股本:
271.63万
流通股本:
100.62万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-11.8955
每股收益(LYR):
-22.3097
净资产收益率:
-125.45%
总资产收益率:
-229.57%
市净率:
-0.09
市盈率(LYR):
-0.02
数据加载中...
总览
公司
新闻资讯
公告
Abpro Holdings, Inc盘中异动 早盘股价大涨75.66%
市场透视
·
02/10
Abpro Holdings, Inc盘中异动 早盘股价大涨6.48%报2.50美元
市场透视
·
01/29
Abpro与Celltrion达成全球合作 临床试验预计2026年上半年启动
美股速递
·
01/06
Abpro与Celltrion宣布其领先多特异性抗体抗癌候选药物Abp-102/Ct-P72获美国FDA IND许可
美股速递
·
01/06
Abpro Holdings, Inc盘中异动 早盘股价大跌5.69%
市场透视
·
01/06
ABPRO HLDGS INC提交IND申请以启动Abp-102/Ct-P72针对HER2阳性癌症的I期临床试验
美股速递
·
2025/12/15
ABPRO控股公司提交有关可发行和转售高达978万股普通股的招股说明书 - SEC文件
投资观察
·
2025/11/20
ABPRO HLDGS INC:提交关于提供和转售高达978万股普通股的招股说明书 - SEC备案
美股速递
·
2025/11/07
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ABP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ABP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABP\",,,,,undefined,":{"symbol":"ABP","market":"US","secType":"STK","nameCN":"ABPRO HLDGS INC","latestPrice":0.522,"timestamp":1772053200000,"preClose":0.522,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":1006226,"shares":2716278,"eps":-11.895451,"marketStatus":"退市","change":0,"latestTime":"02-25 17:30:46 EST","open":0.522,"high":0.522,"low":0.522,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-11.895451,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772067600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1526011200000,"exchange":"NASDAQ","adjPreClose":0.522,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABP\",,,,,undefined,":{"symbol":"ABP","floatShares":1006226,"roa":"-229.57%","roe":"-125.45%","lyrEps":-22.309734,"shares":2716278,"dividePrice":0,"high":0.522,"amplitude":0,"preClose":0.522,"low":0.522,"week52Low":0.51705,"pbRate":"-0.09","week52High":29.97,"institutionHeld":0,"latestPrice":0.522,"eps":-11.895451,"divideRate":0,"volume":0,"delay":0,"ttmEps":-11.895451,"open":0.522},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-23","symbol":"ABP","reason":null,"defaultRemindTime":1771857000000,"announcedDate":"2026-02-20","type":"delisting","dateTimestamp":1771822800000},{"market":"US","date":"2025-11-14","symbol":"ABP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-03","symbol":"ABP","defaultRemindTime":1762180200000,"type":"split","dateTimestamp":1762146000000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABP","date":"2026-02-20","current":-0.043882,"percent":0.990415,"low":-23.177979,"twenty":-4.023113,"median":-1.432052,"eighty":-1.097413,"high":-0.133032,"avg":-2.801188,"sd":3.534508,"marketCap":2173294},"quantilePoints":[{"date":"2024-11-22","current":-19.866839,"twenty":-22.778143,"median":-21.303749,"eighty":-20.955892,"marketCap":160663127},{"date":"2024-11-29","current":-8.390781,"twenty":-21.853523,"median":-19.866839,"eighty":-18.304981,"marketCap":136412089},{"date":"2024-12-06","current":-4.81693,"twenty":-21.258393,"median":-18.273744,"eighty":-7.899765,"marketCap":78310643},{"date":"2024-12-13","current":-4.972315,"twenty":-20.411365,"median":-8.390781,"eighty":-5.307946,"marketCap":80836793},{"date":"2024-12-20","current":-4.630468,"twenty":-19.585704,"median":-7.054472,"eighty":-4.754776,"marketCap":75279264},{"date":"2024-12-27","current":-9.354167,"twenty":-19.01094,"median":-7.505088,"eighty":-4.779638,"marketCap":152074217},{"date":"2025-01-03","current":-4.879084,"twenty":-18.367455,"median":-7.054472,"eighty":-4.829361,"marketCap":79321103},{"date":"2025-01-10","current":-4.008929,"twenty":-18.117558,"median":-6.526163,"eighty":-4.754776,"marketCap":65174664},{"date":"2025-01-17","current":-4.195391,"twenty":-13.953559,"median":-5.562777,"eighty":-4.242006,"marketCap":68206044},{"date":"2025-01-24","current":-8.381212,"twenty":-10.274045,"median":-5.5317,"eighty":-4.189176,"marketCap":64669434},{"date":"2025-01-31","current":-6.744257,"twenty":-8.628186,"median":-6.060009,"eighty":-4.195391,"marketCap":52038685},{"date":"2025-02-07","current":-7.00617,"twenty":-8.401963,"median":-6.285909,"eighty":-4.232683,"marketCap":54059605},{"date":"2025-02-14","current":-6.6133,"twenty":-8.390781,"median":-6.457638,"eighty":-4.503052,"marketCap":51028225},{"date":"2025-02-21","current":-6.154953,"twenty":-8.38504,"median":-6.460736,"eighty":-4.568314,"marketCap":47491616},{"date":"2025-02-28","current":-3.797737,"twenty":-8.263352,"median":-6.416866,"eighty":-4.434578,"marketCap":29303337},{"date":"2025-03-07","current":-3.478858,"twenty":-8.177857,"median":-6.257426,"eighty":-4.18296,"marketCap":26842867},{"date":"2025-03-14","current":-3.080096,"twenty":-7.787294,"median":-5.687085,"eighty":-4.028744,"marketCap":23766017},{"date":"2025-03-21","current":-3.000867,"twenty":-7.524374,"median":-5.506113,"eighty":-3.915698,"marketCap":23154689},{"date":"2025-03-28","current":-2.695084,"twenty":-7.520626,"median":-4.979619,"eighty":-3.467596,"marketCap":20795265},{"date":"2025-04-04","current":-2.363764,"twenty":-7.50198,"median":-4.894623,"eighty":-3.339389,"marketCap":18238801},{"date":"2025-04-11","current":-1.71422,"twenty":-7.395956,"median":-4.754776,"eighty":-3.180932,"marketCap":13226920},{"date":"2025-04-17","current":-1.742819,"twenty":-7.202605,"median":-4.630468,"eighty":-3.128942,"marketCap":12604067},{"date":"2025-04-25","current":-2.345012,"twenty":-7.00617,"median":-4.528423,"eighty":-2.892566,"marketCap":16959130},{"date":"2025-05-02","current":-1.551534,"twenty":-6.927596,"median":-4.242006,"eighty":-2.702941,"marketCap":11220693},{"date":"2025-05-09","current":-1.374418,"twenty":-6.783544,"median":-4.179852,"eighty":-2.352513,"marketCap":9939792},{"date":"2025-05-16","current":-1.878135,"twenty":-6.694312,"median":-4.040006,"eighty":-2.089541,"marketCap":13582675},{"date":"2025-05-23","current":-1.041496,"twenty":-6.619394,"median":-4.01039,"eighty":-1.859432,"marketCap":11905342},{"date":"2025-05-30","current":-1.204886,"twenty":-6.618175,"median":-3.977852,"eighty":-1.811326,"marketCap":14163434},{"date":"2025-06-06","current":-1.097842,"twenty":-6.6133,"median":-3.797737,"eighty":-1.715791,"marketCap":12905137},{"date":"2025-06-13","current":-1.196095,"twenty":-6.589728,"median":-3.46478,"eighty":-1.630882,"marketCap":14060096},{"date":"2025-06-20","current":-1.080777,"twenty":-6.49544,"median":-3.411666,"eighty":-1.551534,"marketCap":12704539},{"date":"2025-06-27","current":-1.153174,"twenty":-6.482344,"median":-3.339389,"eighty":-1.416926,"marketCap":13555561},{"date":"2025-07-03","current":-0.972183,"twenty":-6.482344,"median":-3.198611,"eighty":-1.323927,"marketCap":11428007},{"date":"2025-07-11","current":-1.00683,"twenty":-6.447771,"median":-3.167836,"eighty":-1.217296,"marketCap":11835281},{"date":"2025-07-18","current":-1.014586,"twenty":-6.434171,"median":-3.123966,"eighty":-1.154034,"marketCap":11926462},{"date":"2025-07-25","current":-1.376052,"twenty":-6.420079,"median":-2.994646,"eighty":-1.153174,"marketCap":16175493},{"date":"2025-08-01","current":-1.336234,"twenty":-6.3121,"median":-2.818837,"eighty":-1.154034,"marketCap":15707431},{"date":"2025-08-08","current":-1.238499,"twenty":-6.285909,"median":-2.704251,"eighty":-1.166021,"marketCap":14558551},{"date":"2025-08-15","current":-1.639965,"twenty":-6.240336,"median":-2.685262,"eighty":-1.173707,"marketCap":20169933},{"date":"2025-08-22","current":-1.590427,"twenty":-6.169751,"median":-2.320925,"eighty":-1.191855,"marketCap":19560666},{"date":"2025-08-29","current":-1.588472,"twenty":-5.780659,"median":-2.226259,"eighty":-1.203128,"marketCap":19536616},{"date":"2025-09-05","current":-1.596946,"twenty":-5.6125,"median":-1.931607,"eighty":-1.214194,"marketCap":19640833},{"date":"2025-09-12","current":-1.061154,"twenty":-5.544131,"median":-1.862549,"eighty":-1.187614,"marketCap":13051133},{"date":"2025-09-19","current":-1.303629,"twenty":-5.500996,"median":-1.827834,"eighty":-1.181348,"marketCap":16033333},{"date":"2025-09-26","current":-1.39032,"twenty":-5.194246,"median":-1.77831,"eighty":-1.186042,"marketCap":17099550},{"date":"2025-10-03","current":-1.488744,"twenty":-4.989128,"median":-1.733827,"eighty":-1.192178,"marketCap":18310066},{"date":"2025-10-10","current":-1.287334,"twenty":-4.975237,"median":-1.708327,"eighty":-1.20137,"marketCap":15832916},{"date":"2025-10-17","current":-1.225411,"twenty":-4.935023,"median":-1.674511,"eighty":-1.199339,"marketCap":15071333},{"date":"2025-10-24","current":-1.304281,"twenty":-4.891515,"median":-1.660419,"eighty":-1.202667,"marketCap":16041350},{"date":"2025-10-31","current":-1.277556,"twenty":-4.841792,"median":-1.639965,"eighty":-1.214194,"marketCap":15712666},{"date":"2025-11-07","current":-1.217697,"twenty":-4.779638,"median":-1.630228,"eighty":-1.199339,"marketCap":14976457},{"date":"2025-11-14","current":-1.276251,"twenty":-4.754776,"median":-1.62238,"eighty":-1.201896,"marketCap":15696607},{"date":"2025-11-21","current":-1.432202,"twenty":-4.680191,"median":-1.603789,"eighty":-1.201896,"marketCap":16990210},{"date":"2025-11-28","current":-1.557,"twenty":-4.605606,"median":-1.597597,"eighty":-1.204115,"marketCap":18470690},{"date":"2025-12-05","current":-1.458543,"twenty":-4.568314,"median":-1.596946,"eighty":-1.21001,"marketCap":17302690},{"date":"2025-12-12","current":-1.357795,"twenty":-4.536401,"median":-1.58945,"eighty":-1.218131,"marketCap":16107528},{"date":"2025-12-19","current":-1.096769,"twenty":-4.434578,"median":-1.579998,"eighty":-1.204115,"marketCap":13010971},{"date":"2025-12-26","current":-1.083031,"twenty":-4.331319,"median":-1.565703,"eighty":-1.196744,"marketCap":12847994},{"date":"2026-01-02","current":-0.968545,"twenty":-4.242006,"median":-1.557,"eighty":-1.186302,"marketCap":11489855},{"date":"2026-01-09","current":-0.929621,"twenty":-4.195391,"median":-1.545517,"eighty":-1.160882,"marketCap":11028088},{"date":"2026-01-16","current":-0.815135,"twenty":-4.195391,"median":-1.511537,"eighty":-1.153174,"marketCap":9669949},{"date":"2026-01-23","current":-0.664862,"twenty":-4.170529,"median":-1.486355,"eighty":-1.146978,"marketCap":7887256},{"date":"2026-01-30","current":-0.446493,"twenty":-4.114591,"median":-1.470493,"eighty":-1.135385,"marketCap":5296742},{"date":"2026-02-06","current":-0.343456,"twenty":-4.052437,"median":-1.458543,"eighty":-1.111545,"marketCap":4074417},{"date":"2026-02-13","current":-0.189817,"twenty":-4.040006,"median":-1.451644,"eighty":-1.104358,"marketCap":2251794},{"date":"2026-02-20","current":-0.183199,"twenty":-4.023113,"median":-1.432052,"eighty":-1.097413,"marketCap":2173294}],"updateTime":1772031066021},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610372279","title":"Abpro Holdings, Inc盘中异动 早盘股价大涨75.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610372279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610372279?lang=zh_cn&edition=fundamental","pubTime":"2026-02-10 22:31","pubTimestamp":1770733885,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时31分,Abpro Holdings, Inc股票出现波动,股价急速上涨75.66%。Abpro Holdings, Inc股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Quince Therapeutics, Inc.、Abpro Holdings, Inc、Evommune, Inc.涨幅较大,Abpro Holdings, Inc、Phio Pharmaceuticals Corp.、Quince Therapeutics, Inc.较为活跃,换手率分别为966.30%、615.27%、407.39%,振幅较大的相关个股有Quince Therapeutics, Inc.、Abpro Holdings, Inc、Liminatus Pharma, Inc.,振幅分别为16.62%、15.79%、9.58%。Abpro Holdings, Inc公司简介:Abpro Holdings Inc 是一家致力于开发下一代抗体疗法的生物技术公司,其目标是改善患有严重和危及生命疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223125a49405ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223125a49405ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"2607067989","title":"Abpro Holdings, Inc盘中异动 早盘股价大涨6.48%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607067989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607067989?lang=zh_cn&edition=fundamental","pubTime":"2026-01-29 22:39","pubTimestamp":1769697540,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日22时39分,Abpro Holdings, Inc股票出现波动,股价大幅上涨6.48%。截至发稿,该股报2.50美元/股,成交量1.4446万股,换手率0.53%,振幅4.25%。Abpro Holdings, Inc股票所在的生物技术行业中,整体涨幅为0.14%。Abpro Holdings, Inc公司简介:Abpro Holdings Inc 是一家致力于开发下一代抗体疗法的生物技术公司,其目标是改善患有严重和危及生命疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012922390097a4033e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012922390097a4033e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"1193338956","title":"Abpro与Celltrion达成全球合作 临床试验预计2026年上半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1193338956","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193338956?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 20:01","pubTimestamp":1767700881,"startTime":"0","endTime":"0","summary":"ABPRO HLDGS INC近日宣布,通过与韩国生物制药企业Celltrion的全球战略合作,其创新药物临床试验计划预计将于2026年上半年正式启动。此次合作将整合Abpro在抗体疗法领域的技术优势与Celltrion的规模化生产实力,共同推进肿瘤治疗领域的研发进程。根据双方协议,Abpro将负责前期研发及临床方案设计,Celltrion则承担临床阶段的生产供应与全球商业化支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABP"],"gpt_icon":0},{"id":"1133031799","title":"Abpro与Celltrion宣布其领先多特异性抗体抗癌候选药物Abp-102/Ct-P72获美国FDA IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1133031799","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133031799?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 20:01","pubTimestamp":1767700876,"startTime":"0","endTime":"0","summary":"Abpro公司与Celltrion公司联合宣布,其核心多特异性抗体抗癌候选药物Abp-102(亦称为Ct-P72)已获得美国食品药品监督管理局(FDA)的新药临床试验(IND)批准。\n这一重要进展标志着该创新疗法正式获准进入临床开发阶段,为后续的人体试验铺平道路。Abp-102/Ct-P72作为一种多特异性抗体,旨在通过靶向多个癌症信号通路,更有效地攻击肿瘤细胞。\n此次IND获批是基于临床前研究显示的积极数据,证明了其在治疗特定癌症类型方面的潜力。两家公司计划迅速推进临床试验,以评估该药物在患者中的安全性和有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"2601483161","title":"Abpro Holdings, Inc盘中异动 早盘股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601483161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601483161?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 00:17","pubTimestamp":1767629820,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日00时17分,Abpro Holdings, Inc股票出现波动,股价急速下挫5.69%。Abpro Holdings, Inc股票所在的生物技术行业中,整体跌幅为1.80%。Abpro Holdings, Inc公司简介:Abpro Holdings Inc 是一家致力于开发下一代抗体疗法的生物技术公司,其目标是改善患有严重和危及生命疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106001700953c05cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106001700953c05cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABP"],"gpt_icon":0},{"id":"1137956025","title":"ABPRO HLDGS INC提交IND申请以启动Abp-102/Ct-P72针对HER2阳性癌症的I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1137956025","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137956025?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 20:02","pubTimestamp":1765800144,"startTime":"0","endTime":"0","summary":"ABPRO HLDGS INC提交IND申请以启动Abp-102/Ct-P72针对HER2阳性癌症的I期临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABP"],"gpt_icon":0},{"id":"1141509871","title":"ABPRO控股公司提交有关可发行和转售高达978万股普通股的招股说明书 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1141509871","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141509871?lang=zh_cn&edition=fundamental","pubTime":"2025-11-20 01:08","pubTimestamp":1763572117,"startTime":"0","endTime":"0","summary":"11月7日 - ABPRO控股公司宣布,已向美国证券交易委员会(SEC)提交招股说明书,内容涉及可发行和转售高达978万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABP"],"gpt_icon":0},{"id":"1105117866","title":"ABPRO HLDGS INC:提交关于提供和转售高达978万股普通股的招股说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1105117866","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105117866?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 20:45","pubTimestamp":1762519515,"startTime":"0","endTime":"0","summary":"ABPRO HLDGS INC:提交关于提供和转售高达978万股普通股的招股说明书 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABP","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}